Suvimol Adrian
C. Hill, MD M. Di Bisceglie,
Gaucher Findings
Bonita MD
M. Damaska, RT Roscoe 0. Brady,
#{149}
Disease: Abdominal in 40 Patients’
Abdominal magnetic resonance imaging findings were reviewed in 46 patients with Gaucher disease. All patients had hepatosplenomegaly at the time of initial imaging. Splenic nodules were present in 14 patients (30%) and varied in signal intensity. These nodules were isointense on Ti-weighted and hypointense on T2weighted images. Splenic infarcts were seen in 15 patients (33%), and four of these patients (9%) also had subcapsular fluid collections. Both nodules and infarcts were present in the spleen in four patients (9%). Pathologic correlation was performed with specimens from two patients who underwent partial splenectomy. Focal areas of abnormal signal intensity were noted in the liver in nine patients (20%). They were either stellate or segmental, and may represent fibrotic septa with ischemic changes associated with aggregates of Gaucher cells. No changes were noted in the kidneys or abdominal lymph nodes. Index
terms:
Liver, Spleen,
diseases, diseases,
Radiology
I
From
Gaucher 761.67 775.67
disease,
775.67, 761.67 Liver, MR, 761.1214 #{149} Spleen, MR. 775.1214
#{149}
1992; 184:561-566
the
Department
of Diagnostic
Radiol-
AL.);
and Department
of Pathology,
Children’s Hospital National Medical Center, Washington, DC (K.P.). Received December 6, 1991; revision requested January 6, 1992; revision received March 24; accepted April 6. Address reprint requests to S.C.H. C RSNA, 1992
MD
MR
Imaging
8 7 a)
0 0 0)
E z 1
0 2000
2500
3000 Repetition
Figure
1.
Gaucher
G
Distribution
of TRs
used
in transaxial
3500
Time,
4000
Tr (msec)
T2-weighted
imaging
of 46 patients
with
disease.
disease is a multisystem hereditary disorder caused by the accumulation of a glycolipid called glucocerebroside within the
and the Gaucher
bone marrow cells, leading
disordered graphic
coagulation findings in the
lysosomes
patients with Gaucher disease have been described (4,5), as have the computed tomographic and sonographic findings in the liver and spleen (6,7). There has been only one case report, to our knowledge, of the magnetic resonance (MR) imaging appearance
AUCHER
of macrophages
in systemic
organs. The illness is due to deficient activity of the enzyme glucocerebrosidase (1). Patients with type 1 Gaucher disease
ogy (S.C.H., B.M.D., AL.), Liver Diseases Section, National Institute of Diabetes and Digestive and Kidney Diseases (A.M.D.B.), and Developmental and Metabolic Neurology Branch, National Institute of Neurological Disorders and Stroke (ROB., N.W.B.), Bldg 10, Rm 1C-660, Clinical Center, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892; Department of Radiology, Georgetown University Medical Center, Washington, DC
(S.C.H.,
Alexander Ling, MD #{149}Kathleen Patterson, MD #{149}Norman W. Barton, MD, PhD #{149}
#{149}
exhibit
progressive
anemia,
thrombocytopenia, hepatosplenomegaly, skeletal damage, and occasionally pulmonary and renal difficulties. The nervous system is not involved in this phenotype. Patients with type 2 Gaucher disease (acute neuronopathic form) exhibit hepatosplenomegaly
within
the
first
6
months of life. In addition, they have severe progressive neurologic deterioration and die between 1 and 2 years of age. Patients with type 3 Gaucher disease may have many if not all of the signs of type 1 patients and also have neurologic involvement, including horizontal gaze paresis, myoclonic seizures, and progressive dementia. The liver and spleen in patients with Gaucher disease are enlarged
of the
with
liver
this
study,
and
by and
(2,3). Radioskeleton in
spleen
disorder
we
is infiltrated to anemia
in patients
(8). In the present
describe
the
MR
imaging
findings in the liver and spleen in 46 patients with Gaucher disease and report the frequency of focal abnormalities
within
these
MATERIALS Forty-six
male), (mean
Abbreviation:
AND
patients
ranging age, 23
organs.
(22 male
in age from years)
TR
METhODS
and
=
repetition
and
24 fe-
2 to 51 years with a diagnosis
time.
561
Table MR
1 Imaging
Findings
Liver
in
Spleen
and
in Pediatric
Patients
with
1 or 3 Gaudier
Type
Disease
Organ
Volume Patient!
(cm3)
Weight
Age (y)/Sex 1/2/Mt 2/3/M 3/6/Ft 4/6/M 5/6/M 6/7/F 7/7/M 8/7/M 9/8/F 10/8/F 11/8/F 12/9/F 13/10/F 14/10/F 15/10/F 16/11/M 17/11/M 18/13/F 19/15/M
(kg)
Liver
Spleen
16.0 12.5 16.9 19.5
1,188 1,333
2,017 618 1,893
1,156 1,045 883
1,986 1,253 680
1,179
2,108
24.0
1,265
1,899
19.9 23.9 28.0
1,713 1,594 1,182 935 1,583
3,333 2,079
788
22.4
16.5 18.5
23.0
21/16/M 22/17/F
55.2
2,616
4,023 4,546 3,267
23/18/M
49.5
2,499
6,378
20/15/F
1,499
1,497 1,911 1,981 1,515 1,925 1,952
1,172 5,562 3,539 592 1,050
3,005
* Numbers in parentheses are sizes of nodules. t These two patients had type 3 disease; the remaining
Table 2 MR Imaging
Findings
in
Yes No No No No No Yes No No No No No No No No No Yes
316
Liver and
Spleen
pediatric
in Adult
patients
Patients
Size (cm) Nodules*
Other Several
None None None None None None None None None None None None None None None None None None None None None 2 (< 2) 2 (3), 40 (